Article
HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique.
European journal of clinical pharmacology - 1 Mar 2014
Borgiani Paola, Di Fusco Davide, Erba Fulvio, Marazzi Maria C, Mancinelli Sandro, Novelli Giuseppe, Palombi Leonardo, Ciccacci Cinzia
Abstract excerpt
PURPOSE: Nevirapine (NVP) is an anti-retroviral drug used for the treatment of HIV infection, that may cause several severe adverse events, including Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis (SJS/TEN). A recent whole genome association study highlighted a strong association with allopurinol-induced SJS/TEN within the HCP5 and PSORS1C1 genes in the Japanese population. Our aim was to verify the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
